Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Page 1
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis.
Melillo E, Masarone D, Oh JK, Verrengia M, Valente F, Vastarella R, Ammendola E, Pacileo R, Pacileo G. Melillo E, et al. Heart Fail Clin. 2021 Oct;17(4):547-560. doi: 10.1016/j.hfc.2021.05.001. Epub 2021 Jul 22. Heart Fail Clin. 2021. PMID: 34511204 Review.
Advanced heart failure, an end-stage disease characterized by high mortality and morbidity despite standard medical therapy, requires various therapeutic strategies like heart transplant and long-term mechanical circulatory support. Echocardiography is the main imaging tec …
Advanced heart failure, an end-stage disease characterized by high mortality and morbidity despite standard medical therapy, requires variou …
Update on Direct Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardiac Interventional Procedures: From Clinical Trials to Real-World Evidence.
Melillo E, Carbone A, Rago A, Papa AA, D' Onofrio A, Nigro G, Golino P, Russo V. Melillo E, et al. J Cardiovasc Pharmacol. 2020 Mar;75(3):185-199. doi: 10.1097/FJC.0000000000000786. J Cardiovasc Pharmacol. 2020. PMID: 31876798 Review.
Direct oral anticoagulants (DOACs) are considered a first-line therapy for long-term stroke prevention in patients with nonvalvular atrial fibrillation (AF) and high thromboembolic risk. ...
Direct oral anticoagulants (DOACs) are considered a first-line therapy for long-term stroke prevention in patients with nonvalvular a …
Prostanoids for Critical Limb Ischemia: A Clinical Review and Consideration of Current Guideline Recommendations.
Meini S, Dentali F, Melillo E, de Donato G, Mumoli N, Mazzone A. Meini S, et al. Among authors: melillo e. Angiology. 2020 Mar;71(3):226-234. doi: 10.1177/0003319719889273. Epub 2019 Nov 26. Angiology. 2020. PMID: 31769315 Review.
Different prostanoid drugs have different evidence of efficacy, thus using a generic term "prostanoids" is misleading. Unfortunately, the available evidence is often of low quality and probably not sufficient to support an extensive use of prostanoids in all patients, and …
Different prostanoid drugs have different evidence of efficacy, thus using a generic term "prostanoids" is misleading. Unfortunately, …
Transcatheter Aortic Valve Replacement and Cardiac Resynchronization Therapy in Cancer-Related Cardiotoxicity.
Melillo E, Ascione L, Palmiero G, Caso VM, Caso P. Melillo E, et al. J Cardiovasc Echogr. 2018 Oct-Dec;28(4):233-235. doi: 10.4103/jcecho.jcecho_46_18. J Cardiovasc Echogr. 2018. PMID: 30746327 Free PMC article.
We report the case of a 70-year-old woman without cardiovascular risk factors, with a medical history of non-Hodgkin lymphoma and chronic myeloid leukemia treated with chemotherapy and radiotherapy, who underwent transcatheter aortic valve replacement for severe aortic stenosis a …
We report the case of a 70-year-old woman without cardiovascular risk factors, with a medical history of non-Hodgkin lymphoma and chronic my …
Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patients.
Melillo E, Lucaccini E, Berchiolli R, Adami D, Nuti M, Dell'Omo G, Farina A, Panigada G, Roberts AT, Meini S. Melillo E, et al. Eur Rev Med Pharmacol Sci. 2016 Dec;20(24):5233-5241. Eur Rev Med Pharmacol Sci. 2016. PMID: 28051243 Free article.
TcpCO2 directly and significantly correlated with the highest risk of mortality and seems to represent a new accurate prognostic criterion of unfavourable short and long-term response to prostanoid. In iloprost group, major amputations were significantly reduced. ...CONCLU …
TcpCO2 directly and significantly correlated with the highest risk of mortality and seems to represent a new accurate prognostic criterion o …
Long-term clinical outcomes in critical limb ischemia--A retrospective study of 181 patients.
Melillo E, Micheletti L, Nuti M, Dell'Omo G, Berchiolli R, Adami D, Farina A, Panigada G, Meini S. Melillo E, et al. Eur Rev Med Pharmacol Sci. 2016;20(3):502-8. Eur Rev Med Pharmacol Sci. 2016. PMID: 26914126 Free article.
To date, several prognostic factors have been identified but the data of long-term follow-up in real life setting are scarce. The aim of our study is to describe a large group of CLI patients and identify possible prognostic factors, in a long-term follow-up. ...CON …
To date, several prognostic factors have been identified but the data of long-term follow-up in real life setting are scarce. The aim …
Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
Melillo E, Nuti M, Pedrinelli R, Buttitta F, Balbarini A. Melillo E, et al. Minerva Cardioangiol. 2006 Aug;54(4):481-98. Minerva Cardioangiol. 2006. PMID: 17016419 English, Italian.
AIM: The aim of this study was to evaluate the capacity of transcutaneous partial pressure of O(2) (TCpO(2)) and CO(2) (TCpCO(2)) to predict clinical response to pharmacological treatment in short- and long-term follow-up of unreconstructable critical limb ischemia (CLI) t …
AIM: The aim of this study was to evaluate the capacity of transcutaneous partial pressure of O(2) (TCpO(2)) and CO(2) (TCpCO(2)) to predict …
Guillain-Barré syndrome: rehabilitation outcome and recent developments.
Melillo EM, Sethi JM, Mohsenin V. Melillo EM, et al. Yale J Biol Med. 1998 Sep-Oct;71(5):383-9. Yale J Biol Med. 1998. PMID: 10527365 Free PMC article.
However, 83 percent of the patients were moderately to severely disabled at the time of discharge. Thirteen out of 37 (35 percent) developed long-term disability. None of the patients died over the period of follow-up. ...
However, 83 percent of the patients were moderately to severely disabled at the time of discharge. Thirteen out of 37 (35 percent) developed …
12 results